BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Lan Huang, PhD$94.8M
Market Cap • 24/04/20242014
(há 10 anos)
2017
(7 years ago)
NASDAQ
Listagem
New York
Sede • New York67
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
BYSISó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.